Irinotecan Plus S-1 Versus S-1 in Patients with Previously Treated Recurrent or Metastatic Esophageal Cancer (ESWN 01): a Prospective Randomized, Multicenter, Open-Labeled Phase 3 Trial
Cancer Communications（2019）
关键词
Esophageal squamous cell carcinoma,Recurrent,Metastasis,Multicenter,open-label,randomized trial,Irinotecan,S-1,Overall survival,Progression-free survival,Objective response rate,Disease control rate
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要